Pharmacoeconomic rationale for switching patients with rheumatic diseases from original biologic disease-modifying antirheumatic drugs to biosimilars in context of the Russian healthcare system
Objective: to analyze the pharmacoeconomic efficiency of biosimilars in context of national healthcare system.Material and methods. Based on the developed interactive pharmacoeconomic model, we made an analysis of the impact on the budget of treatment with biologic disease-modifying antirheumatic dr...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
IMA-PRESS LLC
2022-06-01
|
| Col·lecció: | Современная ревматология |
| Matèries: | |
| Accés en línia: | https://mrj.ima-press.net/mrj/article/view/1309 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|